Chris G. Adigun

1 week ago | healio.com | Gabrielle Capaldo |Chris G. Adigun

Key takeaways: In April, the FDA issued an alert warning of potential serious risks associated with compounded topical finasteride sold by online platforms for hair loss. An expert shares what this means for patient care. Topical formulations of finasteride are widely advertised as an option to treat hair loss in men and women, yet some formulations may pose serious health risks and have recently caught the FDA’s attention.